Ph II Early BC Pre-Surgical Biologic Study

NCT00637026 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Gefitinib

Sponsor

AstraZeneca

Collaborators

[object Object]